A citation-based method for searching scientific literature

Javier González-Maeso, Rosalind L Ang, Tony Yuen, Pokman Chan, Noelia V Weisstaub, Juan F López-Giménez, Mingming Zhou, Yuuya Okawa, Luis F Callado, Graeme Milligan, Jay A Gingrich, Marta Filizola, J Javier Meana, Stuart C Sealfon. Nature 2008
Times Cited: 560







List of co-cited articles
1959 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.
Miguel Fribourg, José L Moreno, Terrell Holloway, Davide Provasi, Lia Baki, Rahul Mahajan, Gyu Park, Scott K Adney, Candice Hatcher, José M Eltit,[...]. Cell 2011
194
39

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
Javier González-Maeso, Noelia V Weisstaub, Mingming Zhou, Pokman Chan, Lidija Ivic, Rosalind Ang, Alena Lira, Maria Bradley-Moore, Yongchao Ge, Qiang Zhou,[...]. Neuron 2007
452
28

Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.
José L Moreno, Patricia Miranda-Azpiazu, Aintzane García-Bea, Jason Younkin, Meng Cui, Alexey Kozlenkov, Ariel Ben-Ezra, Georgios Voloudakis, Amanda K Fakira, Lia Baki,[...]. Sci Signal 2016
61
40

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
José L Moreno, Terrell Holloway, Laura Albizu, Stuart C Sealfon, Javier González-Maeso. Neurosci Lett 2011
132
21

Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.
José L Moreno, Carolina Muguruza, Adrienne Umali, Steven Mortillo, Terrell Holloway, Fuencisla Pilar-Cuéllar, Giuseppe Mocci, Jeremy Seto, Luis F Callado, Rachael L Neve,[...]. J Biol Chem 2012
76
25

Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.
Hannah K Delille, Judith M Becker, Sabrina Burkhardt, Barbara Bleher, Georg C Terstappen, Martin Schmidt, Axel H Meyer, Liliane Unger, Gerard J Marek, Mario Mezler. Neuropharmacology 2012
64
26

Psychedelics.
David E Nichols. Pharmacol Rev 2016
417
16

Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS.
Shen Yin, Meredith J Noetzel, Kari A Johnson, Rocio Zamorano, Nidhi Jalan-Sakrikar, Karen J Gregory, P Jeffrey Conn, Colleen M Niswender. J Neurosci 2014
80
17

A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors.
Etienne Doumazane, Pauline Scholler, Jurriaan M Zwier, Eric Trinquet, Philippe Rondard, Jean-Philippe Pin. FASEB J 2011
198
14

Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
Cullen L Schmid, Kirsten M Raehal, Laura M Bohn. Proc Natl Acad Sci U S A 2008
141
14

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
222
14

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Sandeep T Patil, Lu Zhang, Ferenc Martenyi, Stephen L Lowe, Kimberley A Jackson, Boris V Andreev, Alla S Avedisova, Leonid M Bardenstein, Issak Y Gurovich, Margarita A Morozova,[...]. Nat Med 2007
783
12

G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
Sergi Ferré, Vicent Casadó, Lakshmi A Devi, Marta Filizola, Ralf Jockers, Martin J Lohse, Graeme Milligan, Jean-Philippe Pin, Xavier Guitart. Pharmacol Rev 2014
383
12

Hallucinogens.
David E Nichols. Pharmacol Ther 2004
683
12

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
F X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, D Hell. Neuroreport 1998
470
12

Organization and functions of mGlu and GABAB receptor complexes.
Jean-Philippe Pin, Bernhard Bettler. Nature 2016
126
12



Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.
Xavier Viñals, Estefanía Moreno, Laurence Lanfumey, Arnau Cordomí, Antoni Pastor, Rafael de La Torre, Paola Gasperini, Gemma Navarro, Lesley A Howell, Leonardo Pardo,[...]. PLoS Biol 2015
101
11


Structural insights into the activation of metabotropic glutamate receptors.
Antoine Koehl, Hongli Hu, Dan Feng, Bingfa Sun, Yan Zhang, Michael J Robertson, Matthew Chu, Tong Sun Kobilka, Toon Laeremans, Jan Steyaert,[...]. Nature 2019
132
11

Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Colleen M Niswender, P Jeffrey Conn. Annu Rev Pharmacol Toxicol 2010
11

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
426
11

Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling.
Driss El Moustaine, Sébastien Granier, Etienne Doumazane, Pauline Scholler, Rita Rahmeh, Patrick Bron, Bernard Mouillac, Jean-Louis Banères, Philippe Rondard, Jean-Philippe Pin. Proc Natl Acad Sci U S A 2012
120
10


Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells.
David Moreno Delgado, Thor C Møller, Jeanne Ster, Jesús Giraldo, Damien Maurel, Xavier Rovira, Pauline Scholler, Jurriaan M Zwier, Julie Perroy, Thierry Durroux,[...]. Elife 2017
42
23

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.
Mitsumasa Kurita, Terrell Holloway, Aintzane García-Bea, Alexey Kozlenkov, Allyson K Friedman, José L Moreno, Mitra Heshmati, Sam A Golden, Pamela J Kennedy, Nagahide Takahashi,[...]. Nat Neurosci 2012
177
10

Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.
Aashish Manglik, Andrew C Kruse, Tong Sun Kobilka, Foon Sun Thian, Jesper M Mathiesen, Roger K Sunahara, Leonardo Pardo, William I Weis, Brian K Kobilka, Sébastien Granier. Nature 2012
918
10

G Protein-Coupled Receptor Heteromers.
Ivone Gomes, Mohammed Akli Ayoub, Wakako Fujita, Werner C Jaeger, Kevin D G Pfleger, Lakshmi A Devi. Annu Rev Pharmacol Toxicol 2016
154
10

Serotonin research: contributions to understanding psychoses.
Mark A Geyer, Franz X Vollenweider. Trends Pharmacol Sci 2008
242
10

Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.
Huixian Wu, Chong Wang, Karen J Gregory, Gye Won Han, Hyekyung P Cho, Yan Xia, Colleen M Niswender, Vsevolod Katritch, Jens Meiler, Vadim Cherezov,[...]. Science 2014
361
10

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
485
10

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb,[...]. J Psychopharmacol 2016
411
10

Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer.
Junke Liu, Zongyong Zhang, David Moreno-Delgado, James Ar Dalton, Xavier Rovira, Ana Trapero, Cyril Goudet, Amadeu Llebaria, Jesús Giraldo, Qilin Yuan,[...]. Elife 2017
35
25

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.
Yasmin Schmid, Florian Enzler, Peter Gasser, Eric Grouzmann, Katrin H Preller, Franz X Vollenweider, Rudolf Brenneisen, Felix Müller, Stefan Borgwardt, Matthias E Liechti. Biol Psychiatry 2015
186
9

Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization.
Davide Calebiro, Finn Rieken, Julia Wagner, Titiwat Sungkaworn, Ulrike Zabel, Alfio Borzi, Emanuele Cocucci, Alexander Zürn, Martin J Lohse. Proc Natl Acad Sci U S A 2013
279
9

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
Robin L Carhart-Harris, David Erritzoe, Tim Williams, James M Stone, Laurence J Reed, Alessandro Colasanti, Robin J Tyacke, Robert Leech, Andrea L Malizia, Kevin Murphy,[...]. Proc Natl Acad Sci U S A 2012
372
9


Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
Carolina Muguruza, José L Moreno, Adrienne Umali, Luis F Callado, J Javier Meana, Javier González-Maeso. Eur Neuropsychopharmacol 2013
49
18


Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain.
Andrew S Doré, Krzysztof Okrasa, Jayesh C Patel, Maria Serrano-Vega, Kirstie Bennett, Robert M Cooke, James C Errey, Ali Jazayeri, Samir Khan, Ben Tehan,[...]. Nature 2014
289
9

Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer.
Li Xue, Xavier Rovira, Pauline Scholler, Han Zhao, Jianfeng Liu, Jean-Philippe Pin, Philippe Rondard. Nat Chem Biol 2015
120
9

Mechanism of Assembly and Cooperativity of Homomeric and Heteromeric Metabotropic Glutamate Receptors.
Joshua Levitz, Chris Habrian, Shashank Bharill, Zhu Fu, Reza Vafabakhsh, Ehud Y Isacoff. Neuron 2016
89
10

Crystal Structure of an LSD-Bound Human Serotonin Receptor.
Daniel Wacker, Sheng Wang, John D McCorvy, Robin M Betz, A J Venkatakrishnan, Anat Levit, Katherine Lansu, Zachary L Schools, Tao Che, David E Nichols,[...]. Cell 2017
184
9


Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Martin K Madsen, Patrick M Fisher, Daniel Burmester, Agnete Dyssegaard, Dea S Stenbæk, Sara Kristiansen, Sys S Johansen, Sczabolz Lehel, Kristian Linnet, Claus Svarer,[...]. Neuropsychopharmacology 2019
83
10


Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.
Briony J Catlow, Shijie Song, Daniel A Paredes, Cheryl L Kirstein, Juan Sanchez-Ramos. Exp Brain Res 2013
95
9

Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
Samah Karaki, Carine Becamel, Samy Murat, Clotilde Mannoury la Cour, Mark J Millan, Laurent Prézeau, Joël Bockaert, Philippe Marin, Franck Vandermoere. Mol Cell Proteomics 2014
29
27

Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
G J Marek, R A Wright, D D Schoepp, J A Monn, G K Aghajanian. J Pharmacol Exp Ther 2000
225
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.